{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T22:09:09Z","timestamp":1743026949491,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781461485193"},{"type":"electronic","value":"9781461485209"}],"license":[{"start":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T00:00:00Z","timestamp":1378252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T00:00:00Z","timestamp":1378252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-1-4614-8520-9_23","type":"book-chapter","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T21:01:25Z","timestamp":1380142885000},"page":"283-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IgM Multiple Myeloma"],"prefix":"10.1007","author":[{"given":"Steven R.","family":"Schuster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Mikhael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,4]]},"reference":[{"issue":"1","key":"23_CR00231","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1200\/JCO.2008.17.7865","volume":"27","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA et al. Update on treatment recommendations from the Fourth International Workshop on Waldenstrom\u2019s macroglobulinemia. J Clin Oncol. 2009;27(1):120\u20136.","journal-title":"J Clin Oncol"},{"issue":"25","key":"23_CR00232","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1056\/NEJMct0805626","volume":"360","author":"J-L Harousseau","year":"2009","unstructured":"Harousseau J-L, Moreau P. Autologous hematopoietic stem-cell transplantation for multiple myeloma. N Eng J Med. 2009;360(25):2645\u201354.","journal-title":"N Eng J Med"},{"issue":"4","key":"23_CR00233","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2002-08-2436","volume":"101","author":"H Avet-Loiseau","year":"2003","unstructured":"Avet-Loiseau H et al. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood. 2003;101(4):1570\u20131.","journal-title":"Blood"},{"issue":"5","key":"23_CR00234","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1365-2141.2007.06969.x","volume":"140","author":"S Feyler","year":"2008","unstructured":"Feyler S et al. IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14). Br J Haematol. 2008;140(5): 547\u201351.","journal-title":"Br J Haematol"},{"issue":"2","key":"23_CR00235","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cancergencyto.2006.04.009","volume":"169","author":"RFJ Schop","year":"2006","unstructured":"Schop RFJ et al. 6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance. Cancer Genet Cytogenet. 2006;169(2):150\u20133.","journal-title":"Cancer Genet Cytogenet"},{"issue":"9","key":"23_CR00236","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP et al. MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia. N Eng J Med. 2012;367(9):826\u201333.","journal-title":"N Eng J Med"},{"issue":"11","key":"23_CR00237","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ajh.21845","volume":"85","author":"SR Schuster","year":"2010","unstructured":"Schuster SR et al. IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom\u2019s macroglobulinemia. Am J Hematol. 2010;85(11):853\u20135.","journal-title":"Am J Hematol"},{"issue":"2","key":"23_CR00238","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1053\/sonc.2003.50053","volume":"30","author":"H Avet-Loiseau","year":"2003","unstructured":"Avet-Loiseau H et al. 14q32 translocations discriminate IgM multiple myeloma from Waldenstrom\u2019s macroglobulinemia. Semin Oncol. 2003;30(2):153\u20135.","journal-title":"Semin Oncol"},{"issue":"3","key":"23_CR00239","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/sj.leu.2402374","volume":"16","author":"KA Donovan","year":"2002","unstructured":"Donovan KA et al. IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma. Leukemia. 2002;16(3):382\u20135.","journal-title":"Leukemia"},{"issue":"10","key":"23_CR002310","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4065\/mcp.2010.0520","volume":"85","author":"SV Rajkumar","year":"2010","unstructured":"Rajkumar SV, Kyle RA, Buadi FK. Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence. Mayo Clin Proc. 2010;85(10):945\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"13","key":"23_CR002311","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA et al. Prevalence of monoclonal gammopathy of undetermined significance. N Eng J Med. 2006;354(13):1362\u20139.","journal-title":"N Eng J Med"},{"issue":"9","key":"23_CR002312","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4065\/mcp.2010.0304","volume":"85","author":"SM Ansell","year":"2010","unstructured":"Ansell SM et al. Diagnosis and management of Waldenstrom macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clin Proc. 2010;85(9): 824\u201333.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"23_CR002313","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1080\/10428190701644330","volume":"48","author":"R Baz","year":"2007","unstructured":"Baz R et al. Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma. Leuk Lymphoma. 2007;48(12):2338\u201344.","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"23_CR002314","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.4065\/mcp.2009.0603","volume":"84","author":"SK Kumar","year":"2009","unstructured":"Kumar SK et al. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines. Mayo Clin Proc. 2009;84(12):1095\u2013110.","journal-title":"Mayo Clin Proc"},{"issue":"19","key":"23_CR002315","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1056\/NEJMoa1114138","volume":"366","author":"M Attal","year":"2012","unstructured":"Attal M et al. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. N Eng J Med. 2012;366(19):1782\u201391.","journal-title":"N Eng J Med"},{"issue":"19","key":"23_CR002316","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1056\/NEJMoa1114083","volume":"366","author":"PL McCarthy","year":"2012","unstructured":"McCarthy PL et al. Lenalidomide after stem-cell transplantation for multiple myeloma. N Eng J Med. 2012;366(19):1770\u201381.","journal-title":"N Eng J Med"},{"issue":"2","key":"23_CR002317","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12185-012-1125-7","volume":"96","author":"AA Chanan-Khan","year":"2012","unstructured":"Chanan-Khan AA et al. Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients >\/=65 years old with relapsed or refractory multiple myeloma. Int J Hematol. 2012;96(2):254\u201362.","journal-title":"Int J Hematol"}],"container-title":["Multiple Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-8520-9_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T21:01:17Z","timestamp":1676581277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4614-8520-9_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,4]]},"ISBN":["9781461485193","9781461485209"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-8520-9_23","relation":{},"subject":[],"published":{"date-parts":[[2013,9,4]]},"assertion":[{"value":"4 September 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}